These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 3153188

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. [Influence of beta-lactamases on bacterial resistance (author's transl)].
    Cullmann W.
    Immun Infekt; 1981; 9(3):113-8. PubMed ID: 6972899
    [Abstract] [Full Text] [Related]

  • 43. beta-Lactamases of gram-negative bacteria: new challenges for new drugs.
    Sanders CC.
    Clin Infect Dis; 1992 May; 14(5):1089-99. PubMed ID: 1600011
    [Abstract] [Full Text] [Related]

  • 44. Design, synthesis and microbiological evaluation of ampicillin-tetramic acid hybrid antibiotics.
    Cherian PT, Deshpande A, Cheramie MN, Bruhn DF, Hurdle JG, Lee RE.
    J Antibiot (Tokyo); 2017 Jan; 70(1):65-72. PubMed ID: 27189120
    [Abstract] [Full Text] [Related]

  • 45. Contribution of the cell-surface-associated enzyme in the Zimmermann-Rosselet assay of outer membrane permeability of beta-lactam antibiotics.
    Liu W, Nikaido H.
    Antimicrob Agents Chemother; 1991 Jan; 35(1):177-9. PubMed ID: 2014974
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Outer membrane permeability and beta-lactamase content in Pseudomonas maltophilia clinical isolates and laboratory mutants.
    Mett H, Rosta S, Schacher B, Frei R.
    Rev Infect Dis; 1988 Jan; 10(4):765-9. PubMed ID: 3263685
    [Abstract] [Full Text] [Related]

  • 50. Sensitivity of Escherichia coli to various beta-lactams is determined by the interplay of outer membrane permeability and degradation by periplasmic beta-lactamases: a quantitative predictive treatment.
    Nikaido H, Normark S.
    Mol Microbiol; 1987 Jul; 1(1):29-36. PubMed ID: 3330755
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. [Future development of antibiotics. 1. beta-Lactam antibiotics].
    Sawai T.
    Nihon Rinsho; 1984 Mar; 42(3):524-30. PubMed ID: 6471449
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. The clover-leaf test and inactivation of beta-lactam antibiotics by gram-negative rods.
    Jørgensen PE.
    Chemotherapy; 1985 Mar; 31(2):95-101. PubMed ID: 3872781
    [Abstract] [Full Text] [Related]

  • 57. Molecular evolution of ubiquitous beta-lactamases towards extended-spectrum enzymes active against newer beta-lactam antibiotics.
    Collatz E, Labia R, Gutmann L.
    Mol Microbiol; 1990 Oct; 4(10):1615-20. PubMed ID: 2077352
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Problems and changing patterns of resistance with gram-negative bacteria.
    Acar JF.
    Rev Infect Dis; 1985 Oct; 7 Suppl 4():S545-51. PubMed ID: 3909311
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.